QianJin Pharmaceutical: The restructuring matter will be discussed at the meeting on August 18
I'm PortAI, I can summarize articles.
QianJin Pharmaceutical announced that the company plans to acquire 28.92% equity in Hunan QianJin Xiangjiang Pharmaceutical and 68.00% equity in Hunan QianJin Xieli Pharmaceutical through the issuance of shares and cash payment. The Mergers and Acquisitions Review Committee of the Shanghai Stock Exchange will hold a meeting on August 18, 2025, to review the transaction application
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments